Antidepressants Do Work In Depression While Evidence For Cognitive Behavioural Therapy Is Poorer Say Experts
British Association of Pharmacology evidence-based guidelines published this month by SAGEA new revision of clinical guidelines to help doctors manage patients with depression has challenged the rationale behind the UK government's policy of rolling out of cognitive behavioural therapy (CBT) for milder depression.
Minnesota Health Care Group To Launch Pilot 'Pay-for-Performance' Initiative To Reduce Treatment Costs For Depression
The Buyers Health Care Action Group, a health care purchasing coalition in Minnesota for large employers, on Wednesday announced a pay-for-performance pilot program that will reward physicians who effectively treat depressed patients, the St. Paul Pioneer Press reports.
Connection Between Obesity And Depression
A major review in Clinical Psychology: Science and Practice reveals that research indicates people who are obese may be more likely to become depressed, and people who are depressed may be more likely to become obese.To understand the potential links between obesity and depression, researchers led by Sarah M.
Ex Vivo Results From HIV Positive Individuals With And Without Depression
Infection with human immunodeficiency virus (HIV), which leads to acquired immunodeficiency syndrome (AIDS), is an epidemic of global concern. According to the most recent estimates, released in November 2007, by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO), an estimated 33.
Results Of Brodmann Area 25 Deep Brain Stimulation Pilot Study Offer Hope For Patients With Severe Depression
St. Jude Medical, Inc. (NYSE:STJ) announced pilot study results from the first multi-center study investigating deep brain stimulation (DBS) of Brodmann Area 25 for major depressive disorder. Results of the study, which were presented at the American Psychiatric Association (APA) meeting in Washington, D.
Study Demonstrates Lexapro R Significantly Improves Depression Symptoms In Adolescents
Forest Laboratories, Inc. (NYSE: FRX) announced that study results show Lexapro (escitalopram oxalate) significantly improved symptoms of depression as compared to placebo treatment and was well tolerated in adolescents, aged 12-17, with major depressive disorder (MDD), according to phase III data presented at the 2008 Annual Meeting of the American Psychiatric Association.
Depression Treatments Reviewed By NeuroInvestment
NeuroInvestment announced the release of its May issue, which reviews novel treatments being developed for depression. Even though depression can be argued to be the success story of psychopharmacology, the current array of largely similar monoamine-targeting drugs leave 30% of patients without adequate relief, and incur significantly aversive side effects for the majority.
Wyeth's Pristiq, A New Treatment For Major Depressive Disorder
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced that PRISTIQTM (desvenlafaxine), a new serotonin-norepinephrine reuptake inhibitor (SNRI) approved to treat adult patients with major depressive disorder (MDD), is now available in U.
News From The Canadian Medical Association Journal
1. Selective serotonin reuptake inhibitors confirmed as treatment for depressionIn treating depression, a 6 to 9 month course of selective serotonin reuptake inhibitors following initial recovery after a first episode of depression is confirmed by this study.
Aspect Medical Systems Presents Positive Results Of BRITE Major Depression Study At Scientific Conferences
Aspect Medical Systems, Inc. (NASDAQ: ASPM) will present study results from the BRITE (Biomarkers for Rapid Identification of Treatment Effectiveness) trial in major depression at the Society of Biological Psychiatry and American Psychiatric Association Annual Meetings in Washington D.